Marshall Wace North America’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-377
Closed -$7.22M 1797
2021
Q1
$7.22M Buy
+377
New +$7.22M 0.03% 468